Cardiovascular Medicine

Soluble angiotensin-converting enzyme 2 is transiently elevated in COVID-19 and correlates with specific inflammatory and endothelial markers

This article's authors
1. Annika Lundström
2. Louise Ziegler
3. Sebastian Havervall
4. Ann-Sofie Rudberg
5. Fien von Meijenfeldt
6. Ton Lisman
7. Nigel Mackman
8. Per Sandén
9. Charlotte Thålin
This article has 1 evaluations Latest evaluation on Mar 15, 2021 Published on Mar 5, 2021
Vascular Comorbidities Worsen Prognosis of Patients with Heart Failure Hospitalized with COVID-19

This article's authors
1. Jacob Mok
2. Juan Malpartida
3. Kimberly O’Dell
4. Joshua Davis
5. Cuilan Gao
6. Harish Manyam
This article has 1 evaluations Latest evaluation on Mar 29, 2021 Published on Mar 26, 2021
Vascular Inflammation in Lungs of Patients with Fatal Coronavirus Disease 2019 (COVID-19) Infection: Possible role for the NLRP3 inflammasome

This article's authors
1. Oindrila Paul
2. Jian Qin Tao
3. Leslie Litzky
4. Michael Feldman
5. Kathleen Montone
6. Chamith Rajapakse
7. Christian Bermudez
8. Shampa Chatterjee
This article has 1 evaluations Latest evaluation on Mar 24, 2021 Published on Mar 22, 2021
Platelet Activation by Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) Patient Serum is Blocked by COX, P2Y₁₂ and Kinase Inhibitors

This article's authors
1. Christopher W. Smith
2. Caroline Kardeby
3. Ying Di
4. Gillian C. Lowe
5. William A. Lester
6. Steve P. Watson
7. Phillip L.R. Nicolson
This article has 1 evaluations Latest evaluation on Apr 29, 2021 Published on Apr 27, 2021
Role of Combining Anticoagulant and Antiplatelet Agents in COVID-19 Treatment: A Rapid Review

This article's authors
1. Kamal Matli
2. Raymond Farah
3. Mario Maalouf
4. Christy Costanian
5. Nibal Chamoun
6. Georges Ghanem
This article has 1 evaluations Latest evaluation on Mar 24, 2021 Published on Mar 22, 2021
Leveraging genetic data to elucidate the relationship between Covid-19 and ischemic stroke

This article's authors
1. Verena Zuber
2. Alan Cameron
3. Evangelos P. Myserlis
4. Leonardo Bottolo
5. Israel Fernandez-Cadenas
6. Stephen Burgess
7. Christopher D. Anderson
8. Jesse Dawson
9. Dipender Gill
This article has 1 evaluations Latest evaluation on Mar 15, 2021 Published on Mar 1, 2021
Computational Modeling Identifies Embolic Stroke of Undetermined Source Patients with Potential Arrhythmic Substrate

This article's authors
1. Savannah F. Bifulco
2. Griffin D. Scott
3. Sakher Sarairah
4. Zeinab Birjandian
5. Caroline H. Roney
6. Steven A. Niederer
7. Christian Mahnkopf
8. Peter Kuhnlein
9. Marcel Mitlacher
10. David Tirschwell
11. W. T. Longstreth
12. Nazem Akoum
13. Patrick M. Boyle
This article has 5 evaluations Latest evaluation on Mar 25, 2021 Published on Mar 24, 2021

Soluble angiotensin-converting enzyme 2 is transiently elevated in COVID-19 and correlates with specific inflammatory and endothelial markers

Vascular Comorbidities Worsen Prognosis of Patients with Heart Failure Hospitalized with COVID-19

Vascular Inflammation in Lungs of Patients with Fatal Coronavirus Disease 2019 (COVID-19) Infection: Possible role for the NLRP3 inflammasome

Platelet Activation by Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) Patient Serum is Blocked by COX, P2Y12 and Kinase Inhibitors

Role of Combining Anticoagulant and Antiplatelet Agents in COVID-19 Treatment: A Rapid Review

Leveraging genetic data to elucidate the relationship between Covid-19 and ischemic stroke

Computational Modeling Identifies Embolic Stroke of Undetermined Source Patients with Potential Arrhythmic Substrate

Platelet Activation by Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) Patient Serum is Blocked by COX, P2Y₁₂ and Kinase Inhibitors